We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.CYTOMEDIX, INC. WARRANTWarrant Agreement • May 16th, 2011 • Cytomedix Inc • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledMay 16th, 2011 Company Industry JurisdictionCytomedix, Inc., a Delaware corporation (the “Company”), hereby certifies that, for value received, [_]or his registered assigns (including permitted transferees, the “Holder”), is entitled to purchase from the Company up to a total number of [_] fully paid, validly issued and nonassessable shares of Common Stock (as defined below) (as adjusted from time to time as provided in Section 9 hereof) and each such share (a “Warrant Share”) and all such shares (the “Warrant Shares”) at an exercise price equal to $0.50 (as adjusted from time to time as provided in Section 9 hereof, the “Exercise Price”); at any time and from time to time which Warrant shall be exercisable as set forth in Schedule I hereto through and including, April [_], 2016 (the “Expiration Date”), and subject to the following terms and conditions. This Warrant is one of a series of similar warrants (the “Warrants”) issued pursuant to one of several Limited Guarantee Agreements, dated as of April 28, 2011, by and among the
CYTOMEDIX, INC. WARRANTWarrant Agreement • April 12th, 2010 • Cytomedix Inc • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledApril 12th, 2010 Company Industry JurisdictionCytomedix, Inc., a Delaware corporation (the “Company”), hereby certifies that, for value received, _______ or its registered assigns (including permitted transferees, the “Holder”), is entitled to purchase from the Company up to a total number of _____ fully paid, validly issued and nonassessable shares of Common Stock (as defined below) (as adjusted from time to time as provided in Section 9 hereof) and each such share, a “Warrant Share” and all such shares, the “Warrant Shares”) at an exercise price equal to $__ (or 110% of the volume weighted average prices for the 10-day period preceding the issuance date of the Preferred Stock in connection with this Offering (as adjusted from time to time as provided in Section 9 hereof, the “Exercise Price”)), provided, however, in no event shall such price be less that $__; at any time and from time to time from and after the date of this Warrant (the “Initial Exercise Date”) through and including April 9, 2015 (the “Expiration Date”), and sub